http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8899029

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 1401
issn 0007-0920
1532-1827
issueIdentifier 10
pageRange 1395-1401
publicationName British Journal of Cancer
startingPage 1395
bibliographicCitation Culine S, Theodore C, De Santis M, Bui B, Demkow T, Lorenz J, Rolland F, Delgado F, Longerey B, James N. A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. British Journal of Cancer. 2006 Apr 18;94(10):1395–401. doi: 10.1038/sj.bjc.6603118.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f58bca04662d1b6d5caf6d308e1135c1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c047b18f9f18d987b6c00e9a4023096
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97de05dd0d799138d271d76cf307a258
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dda49d7e3988283e1a48bc355d92a73c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_584714e0c89568fe4afaa31d7851b7a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_496834d7aa8cd7af83b6526288ae5665
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8822750be0c82c39d03fb6b40781775
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_152688be9e2257f77d3aebfda9cfd7df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fafcbdb46e9d814582be09c715bf2fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91d61c4a0ae79e56d8832cb5da83bbbe
date 2006-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2361290
https://pubmed.ncbi.nlm.nih.gov/16622447
https://doi.org/10.1038/sj.bjc.6603118
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
title A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen
discusses http://id.nlm.nih.gov/mesh/M0022672
http://id.nlm.nih.gov/mesh/M0001486
http://id.nlm.nih.gov/mesh/M0288082
http://id.nlm.nih.gov/mesh/M0015422
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014747Q000031
http://id.nlm.nih.gov/mesh/D002295Q000188
http://id.nlm.nih.gov/mesh/D001749Q000188
http://id.nlm.nih.gov/mesh/D000972Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014747Q000627
http://id.nlm.nih.gov/mesh/D002295Q000556
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D009944Q000008
http://id.nlm.nih.gov/mesh/D009944Q000009
http://id.nlm.nih.gov/mesh/D001749Q000473
http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8658
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118218024
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10629256
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21874242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918295
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135873354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243055978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128299169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131

Total number of triples: 82.